Skip to main content

Table 3 Univariate and multivariate analysis of clinicopathologic factors affecting disease-free survival rate

From: Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

   

Univariate analysis

Multivariate analysis

Characteristics

No. of patients

5-y DFS (%)

P

Relative risk (95% CI)

P

Cervical tumor size

     

   ≥5 cm

14

69.2

0.50

0.66

0.53a

   < 5 cm

15

80.0

 

(0.18 – 2.42)

 

Clinical node involvement

     

   Yes

11

70.6

0.49

2.30

0.39

   No

18

81.8

 

(0.35 – 15.10)

 

Stage

     

   IB2

20

73.3

0.83

0.67

0.64

   IIA

9

77.8

 

(0.13 – 3.58)

 

SCC Ag level

     

   ≥5 ng/ml

14

69.2

0.50

1.03

0.45a

   < 5 ng/ml

15

80.0

 

(0.95 – 1.12)

 

VEGF expression

     

   Negative

14

92.3

0.033

11.40

0.037

   Positive

15

60.0

 

(1.15 – 112.58)

 
  1. a Treated as a continuous variable.